<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">02734</article-id><article-id pub-id-type="doi">10.7554/eLife.02734</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Chromosomes and Gene Expression</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group></article-categories><title-group><article-title>Loss of the multifunctional RNA-binding protein RBM47 as a source of selectable metastatic traits in breast cancer</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-12035"><name><surname>Vanharanta</surname><given-names>Sakari</given-names></name><aff><addr-line><named-content content-type="department">Cancer Biology and Genetics Program</named-content></addr-line>, <institution>Memorial Sloan-Kettering Cancer Center</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-12169"><name><surname>Marney</surname><given-names>Christina B</given-names></name><aff><addr-line><named-content content-type="department">Laboratory of Molecular Neuro-Oncology</named-content></addr-line>, <institution>The Rockefeller University</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-12170"><name><surname>Shu</surname><given-names>Weiping</given-names></name><aff><addr-line><named-content content-type="department">Cancer Biology and Genetics Program</named-content></addr-line>, <institution>Memorial Sloan-Kettering Cancer Center</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-12171"><name><surname>Valiente</surname><given-names>Manuel</given-names></name><aff><addr-line><named-content content-type="department">Cancer Biology and Genetics Program</named-content></addr-line>, <institution>Memorial Sloan-Kettering Cancer Center</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-12172"><name><surname>Zou</surname><given-names>Yilong</given-names></name><aff><addr-line><named-content content-type="department">Cancer Biology and Genetics Program</named-content></addr-line>, <institution>Memorial Sloan-Kettering Cancer Center</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-12173"><name><surname>Mele</surname><given-names>Aldo</given-names></name><aff><addr-line><named-content content-type="department">Laboratory of Molecular Neuro-Oncology</named-content></addr-line>, <institution>The Rockefeller University</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-1070"><name><surname>Darnell</surname><given-names>Robert B</given-names></name><aff><addr-line><named-content content-type="department">Laboratory of Molecular Neuro-Oncology</named-content></addr-line>, <institution>The Rockefeller University</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-1135"><name><surname>Massagué</surname><given-names>Joan</given-names></name><aff><addr-line><named-content content-type="department">Cancer Biology and Genetics Program</named-content></addr-line>, <institution>Memorial Sloan-Kettering Cancer Center</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country><email>j-massague@ski.mskcc.org</email></aff><xref ref-type="fn" rid="conf3"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-9800"><name><surname>Parker</surname><given-names>Roy</given-names></name><role>Reviewing editor</role><aff><institution>University of Colorado</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>04</day><month>06</month><year>2014</year></pub-date><volume>3</volume><elocation-id>e02734</elocation-id><supplementary-material><ext-link xlink:href="elife-02734-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>07</day><month>03</month><year>2014</year></date><date date-type="accepted"><day>31</day><month>05</month><year>2014</year></date></history><permissions><copyright-statement>Copyright © 2014, Vanharanta et al</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Vanharanta et al</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>The mechanisms through which cancer cells lock in altered transcriptional programs in support of metastasis remain largely unknown. Through integrative analysis of clinical breast cancer gene expression datasets, cell line models of breast cancer progression, and mutation data from cancer genome resequencing studies, we identified RNA binding motif protein 47 (RBM47) as a suppressor of breast cancer progression and metastasis. RBM47 inhibited breast cancer re-initiation and growth in experimental models. Transcriptome-wide HITS-CLIP analysis revealed widespread RBM47 binding to mRNAs, most prominently in introns and 3'UTRs. RBM47 altered splicing and abundance of a subset of its target mRNAs. Some of the mRNAs stabilized by RBM47, as exemplified by dickkopf WNT signaling pathway inhibitor 1, inhibit tumor progression downstream of RBM47. Our work identifies RBM47 as an RNA-binding protein that can suppress breast cancer progression and demonstrates how the inactivation of a broadly targeted RNA chaperone enables selection of a pro-metastatic state.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Robert B Darnell, Reviewing editor, eLife.</p></fn><fn fn-type="conflict" id="conf3"><p>Joan Massagué, Reviewing editor, eLife.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#99-09-032) of Memorial Sloan Kettering Cancer Center. All surgery was performed under sodium pentobarbital anesthesia, and every effort was made to minimize suffering.</p></fn></fn-group></back></article>